Dr Hua Xu

Dr Hua Xu joined ASI in 2012 as an analyst and after a sabbatical in USA was promoted to Head of our Clinical Division in March 2021. Hua holds a BSc in chemistry from Beijing University in China and obtained her PhD in chemistry from the Johns Hopkins University, USA.

Hua leads the company’s clinical division that supports drug discovery and is responsible for all the activities related to clinical and pre-clinical research within the GLP/GCP regulatory framework. She has over 16 years of professional experience in analytical R&D in the pharmaceutical and biotech industries.